Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview
Breast cancer (BC), the most common malignancy in women, results from significant alterations in genetic and epigenetic mechanisms that alter multiple signaling pathways in growth and malignant progression, leading to limited long-term survival. Current studies with numerous drug therapies have show...
Main Authors: | Abigail L. Flint, David W. Hansen, LaVauria D. Brown, Laura E. Stewart, Eduardo Ortiz, Siva S. Panda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/24/8891 |
Similar Items
-
Synthesis and Evaluation of the Anti-Oxidant Capacity of Curcumin Glucuronides, the Major Curcumin Metabolites
by: Ambar K. Choudhury, et al.
Published: (2015-12-01) -
Bioavailability enhancement of curcumin via esterification processes: A review
by: Nidhi Agrawal, et al.
Published: (2022-12-01) -
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
by: Marta Claudia Nocito, et al.
Published: (2021-10-01) -
Curcumin Electrochemistry—Antioxidant Activity Assessment, Voltammetric Behavior and Quantitative Determination, Applications as Electrode Modifier
by: Iulia Gabriela David, et al.
Published: (2023-10-01) -
Clinical Evaluation of Oral Curcumin in Prevention of Acute
by: Simin Hemati, et al.
Published: (2011-10-01)